Drugs / PF-06678552
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02079922 | Mar → Jul 2014 | — | Pfizer | Completed | No outcome recorded |
| Phase 1 | NCT01992614 | Dec 2013 → Mar 2014 | — | Pfizer | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PF-06678552 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01992614 ↗ |
| Route | Oral | “single oral doses of PF-06678552” NCT01992614 ↗ |